Blog

What’s next for specialty? Seven predictions for 2016

What’s next for specialty? Seven predictions for 2016

By ZappRx on January 07, 2016

2015 is in the rearview mirror, and in many ways, it was a year like no other for the specialty pharmaceutical...

Read More
Biosimilars: meet 2016’s solution to the specialty drug cost conundrum

Biosimilars: meet 2016’s solution to the specialty drug cost conundrum

By ZappRx on January 05, 2016

If you work in the pharma or biotech industry, you’ve probably heard the buzz about biosimilars. And, there’s a good...

Read More
Page 1 of 1
1